Karma L McKelvey1, Danielle E Ramo2, Kevin Delucchi3, Mark L Rubinstein4. 1. Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143, USA. Electronic address: Karma.McKelvey@ucsf.edu. 2. Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143, USA; Department of Psychiatry, University of California, San Francisco, 401 Parnassus Avenue, Box TRC 0984, San Francisco, CA 94143, USA. 3. Department of Psychiatry, University of California, San Francisco, 401 Parnassus Avenue, Box TRC 0984, San Francisco, CA 94143, USA. 4. Department of Pediatrics, 3333 California Street, Suite 245, San Francisco, CA 94118, USA.
Abstract
PURPOSE: Adolescent smokers are at increased risk for polydrug use, which is associated with more consequences than use of a single drug. Here we classified subgroups of polydrug use among urban adolescent cigarette-smokers; described the sociodemographic, smoking, and depression correlates; and identified three-year outcomes associated with subgroup membership. METHODS: Adolescent cigarette smokers (N=176; Mage=16.1; 35% male; 27% white) completed surveys assessing drug use, smoking characteristics, demographics, and depressive symptoms at baseline and 12, 24, and 36months follow-up. RESULTS: Almost all participants (96%) reported using, on average, two (SD=0.97) substances (including other tobacco products) in addition to cigarettes. Latent class analysis revealed two distinct classes of polydrug users. "Limited Range Use" (84%) class members reported current use of other tobacco, alcohol, and marijuana, as did "Extended Range Use" class members (16%) who also reported current use of "harder drugs" (i.e., cocaine/crack, hallucinogens, ecstasy, and misused prescriptions). The classes did not differ on demographics or baseline likelihood of marijuana (χ2=0.25; p<0.62) or alcohol use (χ2=3.3; p<0.07). At baseline, a larger proportion of Extended Range Use class members reported both smoking the entire cigarette and symptoms of clinical depression. Extended Range Use class membership at baseline predicted higher mean depression scores at 24 and 36months. CONCLUSION: Adolescent cigarette-smokers who reported extended range use (18%) also reported symptoms of clinical depression at baseline and follow-up. These findings indicate a need for early monitoring of depression symptoms and prevention and cessation interventions targeting this high-risk group.
PURPOSE: Adolescent smokers are at increased risk for polydrug use, which is associated with more consequences than use of a single drug. Here we classified subgroups of polydrug use among urban adolescent cigarette-smokers; described the sociodemographic, smoking, and depression correlates; and identified three-year outcomes associated with subgroup membership. METHODS: Adolescent cigarette smokers (N=176; Mage=16.1; 35% male; 27% white) completed surveys assessing drug use, smoking characteristics, demographics, and depressive symptoms at baseline and 12, 24, and 36months follow-up. RESULTS: Almost all participants (96%) reported using, on average, two (SD=0.97) substances (including other tobacco products) in addition to cigarettes. Latent class analysis revealed two distinct classes of polydrug users. "Limited Range Use" (84%) class members reported current use of other tobacco, alcohol, and marijuana, as did "Extended Range Use" class members (16%) who also reported current use of "harder drugs" (i.e., cocaine/crack, hallucinogens, ecstasy, and misused prescriptions). The classes did not differ on demographics or baseline likelihood of marijuana (χ2=0.25; p<0.62) or alcohol use (χ2=3.3; p<0.07). At baseline, a larger proportion of Extended Range Use class members reported both smoking the entire cigarette and symptoms of clinical depression. Extended Range Use class membership at baseline predicted higher mean depression scores at 24 and 36months. CONCLUSION: Adolescent cigarette-smokers who reported extended range use (18%) also reported symptoms of clinical depression at baseline and follow-up. These findings indicate a need for early monitoring of depression symptoms and prevention and cessation interventions targeting this high-risk group.
Authors: Adrian B Kelly; Tracy J Evans-Whipp; Rachel Smith; Gary C K Chan; John W Toumbourou; George C Patton; Sheryl A Hemphill; Wayne D Hall; Richard F Catalano Journal: Addiction Date: 2015-01-26 Impact factor: 6.526
Authors: Kipling M Bohnert; Maureen A Walton; Stella Resko; Kristen T Barry; Stephen T Chermack; Robert A Zucker; Marc A Zimmerman; Brenda M Booth; Frederic C Blow Journal: Am J Drug Alcohol Abuse Date: 2013-11-12 Impact factor: 3.829
Authors: Afton Kechter; Jessica L Barrington-Trimis; Junhan Cho; Jordan P Davis; Jimi Huh; David S Black; Adam M Leventhal Journal: Addict Behav Date: 2021-05-08 Impact factor: 4.591
Authors: Enedina Quiroga; Arrate Pinto-Carral; Isaías García; Antonio J Molina; Tania Fernández-Villa; Vicente Martín Journal: Int J Environ Res Public Health Date: 2018-08-21 Impact factor: 3.390